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The ability of some Sendai virus stocks to strongly activate IFNβ has long been known to be associated with defective-interfering (DI)
genomes. We have compared SeV stocks containing various copyback and internal deletion DI genomes (and those containing only nondefective
(ND) genomes) for their ability to activate reporter genes driven by the IFNβ promoter. We found that this property was primarily due to the
presence of copyback DI genomes and correlated with their ability to self-anneal and form dsRNA. The level of IFNβ activation was found to be
proportional to that of DI genome replication and to the ratio of DI to ND genomes during infection. Over-expression of the viral Vand C proteins
was as effective in blocking the copyback DI-induced activation of the IFNβ promoter as it was in reducing poly-I/C-induced activation, providing
evidence that these DI infections activate IFNβ via dsRNA. Infection with an SeV stock that is highly contaminated with copyback DI genomes is
thus a very particular way of potently activating IFNβ, presumably by providing plentiful dsRNA under conditions of reduced expression of viral
products which block the host antiviral response.
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an innate antiviral response to intracellular RNA virus
replication has recently made great progress. Two DexD/H
box helicases with CARD domains, RIG-I and Mda5/Helicard,
were found to participate in the detection of cytoplasmic
dsRNA (Andrejeva et al., 2004; Yoneyama et al., 2004). dsRNA
is thought to be a common product of RNAvirus infections that
acts as a pathogen-associated molecular pattern (PAMP)
responsible for initiating the innate antiviral response. RIG-I
and Mda5 initiate antiviral responses by coordinately activating
several transcription factors, including NF-κB and IRF-3, that
bind to the IFNβ promoter forming an enhanceosome that
activates this primary host-response gene (McWhirter et al.,
2005). Upon binding dsRNA, the CARD domains of these
helicases are thought to be freed for interaction with the
synonymous domain of MAVS/VISA/cardif/IPS-1, a mitochon-
drial protein which in turn is required for recruiting the kinases
that activate these transcription factors (Xu et al., 2005; Meylan⁎ Corresponding author.
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doi:10.1016/j.virol.2006.03.022et al., 2005; Seth et al., 2005; Kawai et al., 2005). Autocrine
interaction of secreted IFNβ with its cell surface receptor then
closes the “innate immunity loop”, leading to increased IFN-
stimulated gene (ISG) products, such as other IFNs and the
intracellular effectors of the antiviral state (Sen, 2001).
The role of Mda5 in dsRNA signaling to IFNβ was
uncovered because Mda5 binds to the paramyxovirus SV5 V
protein (Andrejeva et al., 2004). This interaction, and that of
other paramyxovirus V proteins, blocks dsRNA signaling, and
this property of V maps to the highly conserved cys-rich domain
at their C-termini (Poole et al., 2002; Andrejeva et al., 2004). V
proteins of different paramyxoviruses, however, are very
different at their N-terminal portions, which accounts for their
otherwise very different properties (Lamb and Kolakofsky,
2001). Rubulavirus V proteins (e.g., SV5, PIV2) are associated
with intracellular and virion nucleocapsids (NCs) and are
important in promoting virus growth. PIV2 which cannot
express the entire V protein is highly debilitated even in the most
permissive cell culture (Nishio et al., 2005). Respirovirus (e.g.,
Sendai virus (SeV)) V proteins, in contrast, are nonstructural
proteins, are not associated with NCs and their expression
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although V expression is not required for replication in cell
culture, SeVVexpression is essential for virulence in mice (Kato
et al., 1997; Delenda et al., 1998). This requirement is
presumably due to its ability to block dsRNA-induced activation
of the IFNβ promoter (Poole et al., 2002) as infection with SeV
that cannot specifically express the V protein strongly activates
IFNβ (Strahle et al., 2003). Finally, in contrast to rubulaviruses,
respirovirus VmRNAs express a nested set of C proteins from an
overlapping ORF, and these C proteins also block the innate
antiviral response, in several ways (e.g., by blocking IFN
signaling) (Gotoh et al., 1999; Garcin et al., 1999).
It is noteworthy that infection with wild-type SeV or SV5
does not normally activate IFNβ. In contrast, infections with
SV5 VΔC (which produces a C-terminally truncated V protein)
or infections with SeV with mutations in either the leader
region, two regions of the C protein or the V protein all lead to
enhanced levels of IFNβ mRNA (He et al., 2002; Strahle et al.,
2003). In the case of SeV, these viral genes also appear to be
involved in preventing activation of inflammatory cytokines
such as IL-8. For SeV, all the viral products that are not known
to play essential roles in the replication process itself (the Vand
C proteins, and leader and trailer RNAs) appear to function in
countering the innate antiviral response. In the context of a
normal, wild-type infection of cells in culture, the effect of these
various viral anti-host-response products is apparently sufficient
to prevent, or severely limit, IFNβ activation.
The IFNβ promoter is normally activated in cells treated
with dsRNA (poly I:poly C, or poly-I/C) or infected with virus.
Sendai virus infection is often used in this respect, and virus
stocks which strongly activate IFNβ are also available
commercially. However, it has long been known that the
remarkable ability of some SeV stocks to induce IFN secretion
in macrophage and other cell lines is related to the presence of
defective-interfering (DI) particles (Johnston, 1981; Poole et al.,
2002), but the nature of the IFN-inducing agent in these stocks
was not examined. Moreover, for VSV, another mononegavirus,
DI particles containing “snap-back” DI genomes (see below)
were found to be very potent inducers of IFN, even in the
absence of co-infecting nondefective (ND) helper virus (Marcus
and Sekellick, 1977; Sekellick and Marcus, 1982). DI particles
contain deleted viral genomes which are generated spontane-
ously as by-products of ND genome replication. DI genomes
have, sine qua non, gained the ability to successfully compete
with their helper ND genomes for the viral replication substrates
provided by the latter; hence, they are also “interfering”
(Perrault, 1981; Lazzarini et al., 1981). Because of their
replicative advantage over ND genomes, DI genomes invariably
accumulate in SeV stocks that are repeatedly passed in eggs,
unless steps to prevent this accumulation are taken.
Nonsegmented negative-strand RNA viruses (NNV) DI
genomes can be of two types, internal deletion or copyback
(Fig. 1). The replicative advantage of internal deletion DI
genomes over ND genomes is not well understood (Garcin et
al., 1994), but that of copyback DI genomes is well studied.
Copyback DI genomes have always replaced the weaker
genomic replication promoter at the 3′ ends of their minusstrands with the stronger antigenomic promoter, and thus both
DI genomes and antigenomes initiate from the same strong
antigenomic promoter. Paramyxovirus replication promoters are
contained within the 3′ terminal 91–96 nt of the genomic RNA
(narrow boxes, Fig. 1), and all natural copyback DI genomes
have copied back 91 nt or more while carrying out this promoter
exchange (see Fig. 1). Although these RNAs contain termini
that are perfectly complementary for ca. 100 nt, DI genomes are
normally present within nucleocapsids (NCs), where their RNA
ends are not free to anneal. However, when SDS is used to
gently dissociate the N protein from RNA, copyback DI
genomes (and antigenomes) rapidly form ssRNA circles with
dsRNA panhandles, as seen in the EM and on biochemical
analysis (Kolakofsky, 1976). Several copyback DI genomes
from independent virus stocks were characterized initially. They
all contained complementary termini of ca. 100 nt in length, and
as expected, the rate at which they circularized on SDS
treatment was inversely proportional to their length.
Similar copyback DI genomes with limited terminal
complementarity are common for VSV. However, VSV, unlike
SeV, also generates an extreme form of copyback DI genome
whose sequences are complementary over their entire length of
ca. 2 kb (snapback DIs) and which form long dsRNA “hairpins”
(of ca. 1000 bp) rather than ss circles upon SDS treatment
(Lazzarini et al., 1981; Perrault, 1981). It is these VSV snapback
DI genomes, like DI 011, that were reported to strongly induce
IFN by themselves, in aged chick embryo fibroblasts (CEFs)
and mouse L cells (Marcus and Gaccione, 1989; Marcus and
Sekellick, 1977). These reports have remained controversial,
however, because this IFN induction was independent of co-
infecting helper virus, whereas Youngner and colleagues found
that it correlated with contaminating ND virus in L cells. These
latter workers, moreover, were unable to find a correlation
between the snapback content of their DIs and IFN induction
(Frey et al., 1979). Sekellick and Marcus also reported that
snapback DI induction of IFN was unaffected by heat treatment
that would inactivate its RNA polymerase, or UV treatment that
would prevent its genome from being copied, and concluded
that this IFN induction was due to a pre-existing molecule that
did not require any synthetic events for its formation (Sekellick
and Marcus, 1982; Marcus and Gaccione, 1989). Disassembly
of DI 011 NCs intracellularly would then appear to be the only
explanation for dsRNA formation. However, as the infection of
a single DI 011 particle per CEF was sufficient to induce a
quantum (maximum) yield of IFN, the manner in which the DI
011 NC is presumably disassembled so efficiently in vivo (to
permit dsRNA formation) remains an enigma as NCs are
generally very stable in vivo.
Given the growing appreciation that dsRNAmay be a common
product of RNAvirus infection that participates in the induction of
the innate antiviral response, we have reexamined the requirement
of SeV DI genomes for the activation of the IFNβ promoter.
Results
Three SeV stocks containing DI genomes (Figs. 1, 2a), as
well as a stock containing only ND genomes, were examined for
Fig. 1. A schematic view of SeV RNA synthesis and DI genomes. The ND (−) genome is shown above, with its 3′ end genomic replication promoter (on the left) and
the complement of the antigenomic replication promoter (at the 5′ end), both contained within the terminal 96 nt, shown as thin boxes. The central protein coding
region, from the beginning of the N ORF to the end of the L ORF, is shown as thicker boxes; these regions are not drawn to scale. Only the N/P junction is shown, the
remaining genes are lumped together as a P/V/C … L. The (+) RNAs transcribed from the ND genome (le RNA and the 6 mRNAs) are shown below the ND genome.
The sole transcript of the ND-antigenome, tr RNA, is shown above. The lines below the ND genome indicate the progress of the replicase when generating internal
deletion (E307) or copyback (H4/ChR1) DI genomes. The structure of the DI (−) genomes is shown below; the dark shading on the left indicates the extent of the
terminal complementarity, which is also indicated in brackets on the left. The inverted triangle indicates the yfp sequence used to tag H4. The arrows below the DI
genomes show the PCR amplification strategy used to clone the DI RNA of the Charles River SeV stock.
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IFNβ promoter. The DI-H4 stock is composed predominantly
of a natural 1410 nt long copyback DI genome, whose termini
are perfectly complementary for 110 nt (Calain et al., 1992).
The DI-S104 stock, like H4, was generated by passage in eggs,
but this stock is composed of 5 major DI species. Only the
smallest DI of this stock has been cloned as DNA and found to
be an internal deletion DI of 1794 nt (called E307) (Engelhorn
et al., 1993). Their termini are complementary for only 12 nt,
like those of ND genomes. However, Northern analysis with a
leader/N gene probe, which anneals specifically to internal
deletion DI genomes, shows that this stock contains 3 internal
deletion as well as 2 copyback DI genomes (the latter of ca.
2500 and 3500 nt in length) (Fig. 2a). DI-GP55, in contrast to
the others, was produced and rescued by recombinant means
(Garcin et al., 1995) and is identical to E307 except that it
contains the 55 nt trailer region at the (−) DI genome 3′ end, in
place of the leader region. DI-GP55 is thus a copyback DI
genome whose termini are complementary for 55 nt (Fig. 1). As
mentioned above, copyback DI genomes with more extensive
terminal complementarity, such VSV DI 011, have not been
reported for SeV, and we have no stable SeV stocks that contain
only internal deletion DI genomes.
Infection of 293T cells with all 3 DI stocks was found to
activate the IFNβ reporter, but to very different extents (Fig. 2c).H4 was the most potent, followed by GP55, and S104 was the
least potent. In contrast, infection with ND genomes alone barely
activated the reporter gene, even though the ND infection
accumulated as much or more viral proteins than the DI
infections (Fig. 2b). In these and other experiments, there is often
an inverse correlation between the accumulation of viral proteins
and the extent of IFNβ activation, as might be expected if
activation is due to the presence of DI genomes. More
importantly, plaque purification of the H4 stock yields a virus
preparation that does not contain DI genomes and which does
not activate the IFNβ promoter during infection (ND-H4, Fig.
3). The ability of the DI-H4 stock to activate IFNβ is thus not due
to mutations within the ND genome, which could have arisen
because of the presence of the DI genomes.
IFNβ activation requires modification of IRF-3, which is
hyper-phosphorylated in response to viral infection, or dsRNA
(Fitzgerald et al., 2003; Sharma et al., 2003). Activated IRF-3
dimerizes andmigrates to the nucleus where it binds to the PRD I
and III elements of the IFNβ promoter, as part of an
enhanceosome (Maniatis et al., 1998). The activation of the
IFNβ promoter by SeV DI infection appears to require IRF-3
since this activation is largely ablated by co-expression of a
dominant-negative form of IRF-3 (data not shown). When the
extent of IRF-3 dimerization was examined, a significant
fraction of the IRF-3 was found as dimers (on non-denaturing
Fig. 2. Only DI infections activate IFNβ in 293T cells. (a) Northern blot of encapsidated (CsCl banded) RNAs from the various infections as indicated, using a (+)
riboprobe from the end of the L gene (which detects all DI genomes) or a (+) riboprobe from the leader/N gene region, which detects only internal deletion DI genomes.
The DI-H4 and GP-55 genomes do not anneal with the leader/N gene probe. (b) A Western blot of equal amounts of cell extracts (total proteins) of the various
infections, using anti-P and anti-N antibodies. (c) 293T cells were transfected with a luciferase reporter plasmid under the control of the IFNβ promoter (and control
plasmid) for 24 h then infected (or not) with the various SeV stocks for 20 h. Cell extracts were prepared, and levels of the renilla and firefly luciferases were
determined. The cumulative results of 3 experiments are shown. (d) Two different amounts (1× and 5×) of total cell proteins from extracts of the various infections were
separated on nondenaturing gels andWestern blotted with anti-IRF-3. (e) Equal amounts of cell extracts of the various infections (total proteins) were separated on SDS
gels andWestern blotted with anti-IRF-3. The right-hand lane shows uninfected cells that express transfected IRF-3 5D. The 5 isoforms, numbered 1 to 5, are indicated.
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formation was roughly in proportion to the degree of IFNβ
activation (Fig. 2d). In contrast, there was no evidence of dimers
in the ND extract.We also examined the electrophoretic mobility
of IRF-3 on SDS-PAGE as this mobility is sensitive to IRF-3
phosphorylation status (Hiscott et al., 2003; Hasegawa et al.,
1992; Yoneyama et al., 2002). We could distinguish 5
electrophoretic forms of IRF-3 in our extracts (Fig. 2e). Mock-
infected extracts predominantly contained forms 2 and 3.
Infection with ND SeV led to the strong appearance of faster
form 5, without loss of 2 and 3. In contrast, infection with DI-H4
and GP55 led to the appearance of the slightly slower form 4,
reduction in the intensity of forms 2 and 3, and the appearance of
the slowest form 1, which co-migrates with phospho-mimetic
IRF-3 5D that is constitutively active (Lin et al., 1999). IRF-3 isthus being modified in response to the ND infection, but these
modifications do not lead to dimerization or the activation of the
IFNβ promoter. The presence of DI genomes during infection
somehow causes IRF-3 to be modified differently, leading to its
dimerization and IFNβ promoter activation.
DI-H4-induced activation of IFNβ is proportional to DI
genome replication
The relative amounts of DI and ND genomes in cell extracts
can be examined by Northern blotting (Figs. 2 and 3), but this
analysis is linear only over a relatively narrow range and often
unequally estimates RNAs that vary significantly in length
(>10-fold in this case). RT/PCR is better suited to this task, but
this method cannot differentiate between DI-H4 and ND
Fig. 4. Evolution of the DI-H4+yfp stock on passage in eggs. (a) The DI-
H4+yfp genome was prepared from DNA by reverse genetics (Methods and
materials) and rescued by superinfecting the BSR T7 culture with ND SeV
(Methods and materials). The culture supernatant was inoculated into eggs, and
the resulting allantoic fluid was diluted 1 to 500 for reinoculation, for a total of 20
times. The stocks from each passage level were assayed for their ability to
activate a GFP gene under the control of the IFNβ promoter. Only the results
from passage levels 8 and 16 to 20 are shown, along with DI-H4 as positive
control and mock-infected as a negative control. (b) Total RNA was prepared
from cells infected with passage levels 8 and 16 to 20 and examined by RT/PCR
for their levels of ND genome (N gene) and DI genome (YFP) relative to that of
GADPH mRNAs. Total RNA from a mock-infected culture served as the
negative control. (c) Equal amounts of extracts from cells infected with passage
levels 8 and 16 to 19 were examined by Western blotting with anti-N and anti-P/
V/C and anti-actin as a loading control.
Fig. 3. Allantoic fluid stocks prepared from plaque-purified SeV do not activate
IFNβ. The DI-H4 and ChR stocks were titered on LLC-MK2 cells in the
absence of serum. Single plaques from the highest positive dilution (10−7) were
picked, and 3/10 of each plaque was inoculated into hen's eggs that were
incubated at 33 °C for 3 days. The allantoic fluid stocks resulting from the
plaque-purified virus (ca. 109 pfu/ml) were compared with the original stocks
containing the same amount of viral proteins (as determined by Coomassie blue
staining of SDS gels) for their ability to activate pIFNβ-GFP in 293T cells. A
Northern blot of encapsidated (CsCl banded) RNAs from equal amounts of ND-,
H4-, and ChR1-infected cells, using a (+) riboprobe from the end of the L gene,
is shown in the insert.
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amplification. However, the dsRNA panhandles of circular DI
genome RNAs are exceedingly stable and cannot be invaded by
primers extended by RTase even at elevated temperatures. To
circumvent these technical problems, we prepared a tagged
version of the DI-H4 genome containing a 162 nt insertion
from the YFP gene (Fig. 1), such that the DI and ND genomes
could be independently and accurately estimated by RT/PCR,
over a large range of values. A second reason for preparing DI-
H4+yfp is that, although our H4 stocks are composed
predominantly of the 1410 nt long species cloned as DNA,
overexposure of Northern blots shows that several other RNAs
are present in much lower amounts and which have not
otherwise been characterized. As we do not know whether all
the DI genomes in the H4 stock contribute equally to inducing
IFNβ activation or whether activation is due to a particular (and
perhaps uncharacterized) species, we cannot be sure that IFNβ
activation is in fact due to the 1410 nt copyback DI genome.
Recapitulation of these results with a tagged copy of the DI-H4
genome would settle this issue as well.
DI-H4+yfp genomes were recovered from DNA in BSR T7
cells that were subsequently co-infected with ND SeV. Stocks
containing this DI genome were then generated by multiple
passages in embyonated chicken eggs (Methods and materials),
and each passage was tested for its ability to activate a GFP
reporter gene under the control of the IFNβ promoter (pIFNβ-
GFP) upon infection of 293T cells. Although some IFNβ
activation above background appeared by passage 3, this
activation increased slowly and erratically at first and eventually
reached activation levels approximately half those of the
reference H4 stock by passage 20 (Fig. 4a), During the later
passages (16 to 20), the level of intracellular ND genomes
steadily decreased (Fig. 4b), leading to a reduction in the levels
of viral proteins (Fig. 4c), whereas the levels of DI-H4+yfpgenomes steadily increased (Fig. 4b). The ability of SeV DI
stocks to induce IFNβ activation thus correlates with the
relative levels of DI genomes during infection. As DI and ND
genome NCs are relatively stable structures, these levels reflect
the rates that DI and ND genomes are synthesized during
infection with the various passage levels. The evolution of the
DI-H4+yfp stock towards IFNβ activation (during relatively
undiluted passage in eggs) thus correlates with the level of DI
genome synthesis during infection. The remarkable ability of
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predominant 1410-nt-long copyback DI genome.
Examination of the UV inactivation kinetics of DI-induced
IFNβ activation, as compared to the UV inactivation kinetics of
ND and DI genome replication, can provide broad information
on the nature of this IFNβ activation. DI-H4+yfp (P(passage)
17, insert, Fig. 5) was irradiated with 256 nm UV light for
various times (0.5 to 8 min) and used to infect 293T cells
containing pIFNβ-GFP. Intracellular RNA was isolated at
20 hpi, and the levels of ND genome RNA and DI-H4+yfp
genome RNAwere measured by RT/PCR. GFP expression was
monitored by FACS (Fig. 5a). DI-H4+yfp (1572 nt) is 1/10 the
length of the ND genome (15,384 nt) and thus proportionately
less sensitive to UV inactivation. This difference in the loss of
ND and DI genome levels is most apparent at the shortest times
of UV irradiation and is lost at the higher doses, presumably
because DI genome replication ultimately depends on ND
genomes to provide all the replication substrates (N, P and L
proteins). The reduction of GFP expression levels uponFig. 5. UV inactivation kinetics of DI-H4+yfp infections. (a) The allantoic fluid
of DI-H4+yfp passage level 17 was irradiated with 254 nm light (110 μW/cm2)
from 0.5 to 8min and then used to infect 293Tcells that had been transfected with
pIFNβ-GFP. Total RNA was prepared at 24 hpi, and the levels of DI-H4+yfp
genome and ND genome were determined by RT/PCR. GFP expression levels
were monitored by FACS. The results are shown relative to RNA from cells
infected with non-irradiated allantoic fluid. The cumulative results of 2
experiments are shown. The error bars, always <20%, are not shown for clarity.
(b) A Northern blot of encapsidated RNAs fromND, DI-H4 and DI-H4+yfp P17
infections, using a (+) probe from the end of the L gene.increasing UV irradiation parallels that of ND and DI genomes
and most closely follows the loss of the DI genomes at the
lowest doses of UV. More importantly, as the reduction of GFP
expression levels closely follows that of DI genomes over a
range of 2 logs, IFNβ activation is clearly proportional to the
level of copyback DI genome replication (in 293T cells) for a
given stock as well.
The manner in which SeV DI genomes presumably generate
dsRNA that induces IFN is thus quite different from that of
VSV DI 011. SeV DI genomes not only require co-infection
with ND helper virus, IFN induction here (293T cells) is strictly
proportional to the level of DI genome replication, in contrast to
VSV snapback DI IFN induction (in aged CEFs) where viral
RNA synthesis is not required.
The SeV stock of Charles Rivers Laboratory
As mentioned above, SeV stocks (Cantell strain) whose
infection of cultured cells strongly activates IFNβ, are available
from Charles River Laboratory. A fresh allantoic fluid stock of
this virus preparation was found to activate IFNβ to levels
similar to those of DI-H4 (Fig. 3), and this stock was found to
contain a very small DI genome (of ∼600 nt) by Northern
analysis (insert, Fig. 3). When the ND virus of this preparation
was plaque purified on LLC-MK2 cells, allantoic fluid stocks
prepared from the purified virus had lost the ability to activate
IFNβ (ND-ChR1, Fig. 3). Thus, similar to DI-H4, the ability of
the Charles River virus preparation to activate IFNβ appears to
be due to the presence of the DI genome(s), and not to mutations
within its ND genome.
To determine the nature of this DI genome, we cloned the
DI genome as DNA, as illustrated in Fig. 1 (small horizontal
arrows are primers). We used one set of primers to amplify
the common right end of all DIs (arrows under GP55, Fig. 1)
and 3 sets of primers that were specific to the left end of
either internal deletion (arrows under E307, Fig. 1) or
copyback DIs (arrows under H4, Fig. 1). The common right
end primer set and the 3 copyback-specific left-end primer
sets all yielded a PCR product of the expected size, whereas
the 3 internal-deletion-specific left-end primers failed to
produce visible DNA (not shown). When these amplified
DNA fragments were sequenced, DI-ChR1 was deduced to be
a simple copyback DI genome of 546 nt (453 nt are co-linear
with the 5′ end of the ND (−) genome), with terminal
complementarity over 93 nt. To our knowledge, this is the
smallest natural SeV DI genome described to date, and this
property may be related to its ability to activate IFNβ so
strongly.
The SeV V and/or C proteins inhibit DI-H4-induced IFNβ
activation
Although our 293T cells produce IFN in response to DI-
H4 infection, they do not respond to added IFN. 293T cells
are thus useful in studying IFNβ activation in isolation
because the activation is not also driven by positive feedback
via ISGs. However, to study the broader aspects of the
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IFN in response to infection and respond as well to the
secreted IFN. When 2fTGH cells containing a pIFNβ-luc
reporter are treated with poly-I/C (either added to the
medium or via transfection (*)) or IFNα, poly-I/C* and H4
infection strongly activate IFNβ promoter, whereas IFNα has
no effect and poly-I/C treatment has little effect (IFNβ is not
an ISG, and TLR3 may be poorly expressed in these
fibroblasts). Moreover, whereas poly-I/C* and IFNα clearly
increased ISG levels (STAT1, RIG-I, ISG15 and ISG56), H4
infection failed to increase these ISG levels above the
untreated control. The SeV V protein blocks poly-I/C-
induced IFNβ activation (Poole et al., 2002) and presumably
should also block that induced by DI-H4 infection. We
reasoned that, if DI-H4 infections generated abnormally large
amounts of dsRNA, the amount of V expressed from the ND
genome during DI infections might be insufficient to block
dsRNA signaling via RIG-I and Mda5. We therefore over-
expressed the V and C proteins by plasmid transfection in
2fTGH cells containing pIFNβ-luc and re-examined the
effects of the various treatments. As shown in Fig. 6a, over-
expression of the V and C proteins was as effective in
blocking the DI-H4-induced activation of the IFNβ promoter
as it was in reducing the poly-I/C*-induced activation. This
result is consistent with the notion that DI-H4 infection
induces IFNβ activation, at least in part, via dsRNA. Over-
expression of the V and C proteins also partially blocked the
poly-I/C*- and IFNα-induced increase in ISG levels,
including that of RIG-I.
To examine whether DI-H4 infection was indeed able to
block IFN signaling, we similarly treated 2fTGH cells
containing a pIRSE-luc reporter and examined the effects on
the reporter gene and ISG protein levels (Fig. 6b). In contrast
to IFNα and poly-I/C* treatment which activated this
promoter and increased ISG levels, DI-H4 infection did not
activate the ISRE reporter over the untreated control, and the
levels of STAT1, RIG-I, ISG15 and ISG56 were not increasedFig. 6. (a) The effect of poly I/C, DI-H4 infection and IFNα treatment on IFNβ
and ISGs in 2fTGH cells, in the presence and absence of the SeV V and C
proteins. 2fTGH cells were transfected with a luciferase reporter plasmid under
the control of the IFNβ promoter (and the TK-renilla control plasmid) and pSeV-
V/C that expresses V and C proteins from the same mRNA (or and empty
plasmid) for 24 h. Parallel cultures were then either treated with 100 μg/ml of
poly I/C in MEM (poly-I/C), transfected with 1 μg of poly I/C (poly I/C*),
infected with DI-H4 or treated with 1000 IU of IFNα. Cell extracts were
prepared 20 h later, and the levels of the renilla and firefly luciferase activities
were determined. The cumulative results of 2 experiments are shown. Equal
amounts of total protein of each extract were also examined for their levels of
STAT1 (and actin), RIG-I, SeV P, V and C proteins and ISG-15 and ISG-56 by
Western blotting with specific antibodies (Methods and materials). (b) The effect
of poly I/C, DI-H4 infection and IFNα treatment on ISGs in 2fTGH cells.
2fTGH cells were transfected with a luciferase reporter plasmid under the
control of an ISRE promoter (and the TK-renilla control plasmid) for 24 h.
Parallel cultures were then treated as in panel A. Cell extracts were prepared 20 h
later, and the levels of the renilla and firefly luciferase activities were
determined. The cumulative results of 2 experiments are shown. Equal amounts
of total protein of each extract were also examined for their levels of STAT1 (and
actin), RIG-I and ISG-15 and ISG-56 by Western blotting.in these extracts. Thus, there appears to be sufficient viral
proteins expressed during DI-H4 infection to block IFN
signaling.
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dsRNA is thought to be a common product or PAMP of RNA
virus infections that initiates the innate antiviral response, in part
by activating IFNβ. However, the source of this dsRNA is
presumably different for different viruses. (+) RNA virus
genomes contain highly conserved 2° and 3° structures at their
5′ and 3′ ends that are essential for virus replication (Simmonds
et al., 2004), and these highly structured RNA regions by
themselves can initiate signaling to IFNβ upon binding to RIG-I
(Sumpter et al., 2005). In contrast, NNV genomes are not known
to contain conserved 2° structures, and, moreover, NNV
genomes function in RNA synthesis not as free RNAs but as
assembled NCs, in which the genome RNA cannot normally
anneal (Lamb and Kolakofsky, 2001). One possible source of
dsRNA during NDSeVreplication is the occasional extension of
the trailer RNA beyond the trailer/L gene junction (see Fig. 1),
producing run-on trailer RNAswhose 3′ sequences can anneal to
those of the L mRNA (Vidal and Kolakofsky, 1989). In a similar
vein, the transcriptase which synthesizes the L mRNA
presumably reads through the L gene-end site at a frequency
of ca. 5% (similar to other gene junctions; Le Mercier et al.,
2002) and terminates at the genome 5′ end, thus providing read-
through L transcripts that can anneal to trailer RNAs. Although
the NNV replication strategy appears to minimize dsRNA
potential during intracellular replication, this strategy presum-
ably cannot exclude the generation of small amounts of dsRNA.
It is reasonable that the levels of V and C expressed during ND
genome replication are designed to counteract the small amounts
of dsRNA generated. If so, the presence of significant amounts
of copyback DI genomes during intracellular replication will
certainly change the nature of the SeV infection.
The most important new finding of this study is that not all
SeV stocks that are heavily contaminated by DI genomes are
equally able to activate IFNβ. The H4, GP55 and S104 stocks all
contain the H strain ND genome as helper and can be directly
compared. S104 infections accumulate more viral products than
H4 infections as the S104 DI genomes appear to interfere less
with their helper virus replication than those of H4 (Fig. 2b). At
the same time, S104 infections activated IFNβ 10 to 20-fold less
strongly than H4 infections in multiple experiments (Fig. 2a and
data not shown). Besides the different extents to which S104 and
H4 DI genomes interfere with ND genome expression and thus
affect the intracellular concentration of the viral VandC proteins,
H4 stocks are composed exclusively of copyback DI genomes,
whereas S104 stocks are composed predominantly (>70%) of
internal deletion DI genomes. Moreover, the two copyback DI
genomes in this stock are both longer than DI-H4. DI-GP55 is
also longer than DI-H4, its termini are complementary for only
half the length as H4 (55 nt), and DI-GP55 interferes with ND
genome expression less than DI-H4. Taken together, these data
suggest that the ability of SeV DI stocks to activate IFNβ is
related both to (i) their ability to interfere with helper genome
expression, which leads to lower levels of Vand C intracellularly,
and (ii) their relative content of copyback DI genomes. The size
of the DI genome may also play a role in this latter respect.
However, it will be necessary to examine these properties of SeVDI genomes more directly, e.g., by extending the terminal
complementarity of DI-GP55 to 110 nt, or by altering the length
of DI-H4+yfp, to be more certain of these conclusions.
Copyback DI genomes may be stronger activators of IFNβ
than internal deletion DI genomes because they have a stronger
potential to form dsRNA. Copyback DI genomes are composed
of equal amounts of genomes and antigenomes (rather than a
10-fold excess of genomes), and their termini can self-anneal
intramolecularly as well. The question then remains of how this
dsRNA potential is expressed as the synthesis of DI genomes,
like that of ND genomes, is thought to be coupled to their
assembly into NCs. The vast majority of these NCs, once
formed, are very stable in vivo and band in CsCl density
gradients as fully assembled NCs. However, it is not rare to find
small amounts of DI-H4 genomes and antigenomes in extracts
of infected cells which pellet through these gradients as free
RNAs (<5%, unpublished). It is not clear whether these non-
assembled DI genomes were normally made as NCs which
subsequently disassembled or were actually made de novo
without concurrent assembly with N protein, as reported for
some conditions of VSV DI genome replication in vitro
(Chanda et al., 1980). Independent of how non-assembled DI-
H4 genomes are presumably generated in vivo, their formation
appears to be proportional to their synthesis (Fig. 4). Their
presence would represent a vast increase in the dsRNA potential
of SeV DI vs. ND infections, under conditions where there is
less V protein available to dampen dsRNA signaling to IFNβ
(Fig. 4c). The relatively short lengths of the H4 and ChR1 DI
genomes may play a role in how frequently their non-assembled
RNAs are formed in vivo, but this needs to be investigated.
There is one further aspect of SeV copyback DI infections that
should be mentioned to explain their ability to induce IFN so
efficiently, coupled with the remarkable fact that these DI
genomes with dsRNA potential are actually selected for on
passage in eggs (e.g., Fig. 4) (Le Mercier et al., 2002). We have
previously prepared ambisense ND SeV in which an additional
mRNA was expressed from the 3′ end of the antigenome. In
contrast to copyback DI genomes, genomes and antigenomes of
the ambisense SeV contain the weaker genomic promoter. These
ambisense SeV grew poorly in IFN-sensitive cultures and were
relatively IFN-sensitive. They were also highly unstable on
passage in eggs and reverted to virus that grows well even in IFN-
pretreated cells that restrict vesicular stomatitis virus replication,
i.e., the wild-type SeV phenotype. Since this reversion was
always associated with a point mutation in the ambi-mRNA start
site that severely limited its expression, we concluded that the
selection ofmutants unable to express ambi-mRNAon passage in
chicken eggs was presumably due to increased levels of dsRNA
during infection (vRdRp read-through of the ambi-mRNA stop
site creates a capped transcript that can potentially extend the
entire length of the antigenome, whereas extension of the
uncapped trailer RNA (wt SeV) is limited by the poor processivity
of its vRdRp). If ND ambisense SeV with dsRNA potential are
strongly selected against in eggs, then how are DI genomes with
dsRNA potential positively selected under the same conditions?
There are two possible explanations for this conundrum.
Firstly, the dsRNA potential of ambisense SeV is not associated
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ambi-mRNA promoter will largely eliminate this potential. The
ND genomes of SeV stocks containing copyback DI genomes,
in contrast, cannot escape their DI genomes by simple mutation,
and the dsRNA potential of copyback DI genomes is always
associated with a strong selective advantage as copyback DI
genomes outcompete their ND genomes for the replication
substrates provided by the latter. Secondly, and perhaps more
importantly, copyback DI infections are relatively non-cyto-
pathic and often end as persistent infections (Roux et al., 1991).
This is in part due to the ectopic expression of trailer RNA (in
place of leader RNA) from the copyback DI (−) genome (Garcin
et al., 1998) (Fig. 1). Trailer RNA is known to interact with
TIAR, a protein with many links to apoptosis, and this
interaction is important in suppressing SeV-induced PCD
(Iseni et al., 2002). The relative absence of leader RNAs during
copyback DI infections may also contribute to this DI
phenotype as mutations in the SeV leader region are associated
with virulence in mice (Fujii et al., 2002), and the normal
expression of leader RNA appears to be required to prevent
IFNβ activation (Strahle et al., 2003). The ability of copyback
DI infections to delay, and in many cases completely prevent
PCD, may compensate for the negative consequences of
increased dsRNA during infection, which presumably selects
against SeV that express ambi-mRNAs.
In summary, infection with an SeV stock that is highly
contaminated with copyback DI genomes is a potent way of
activating IFNβ. These DI infections presumably provide
plentiful dsRNA, under conditions of reduced expression of
viral products which block the host response to dsRNA, and
with minimal cytopathic effects that lead to persistent infection.
In contrast, infection with an SeV stock that is not contaminated
with copyback DI genomes does not activate IFNβ and is
highly cytopathic. These are two very different virus infections,
and they should not be confused when SeV stocks of unknown
composition are used to activate IFNβ.
Methods and materials
Cells, viruses, and antibodies
BSR-T7 cells were grown in BHK-21 Medium (Glasgow
MEM, Gibco) supplemented with 5% fetal calf serum (FCS) in
the presence of the relevant maintenance drug (G418 at 400 μg/
ml). 2fTGH cells and 293T cells were grown in Dulbecco's
modified Eagle's medium supplemented with 10% fetal calf
serum (FCS).
SeV stocks were grown in the allantoic cavities of 9-day-old
embryonated chicken eggs for 3 days at 33 °C. For ND stocks
(109 pfu/ml), 0.1 ml of a 105 dilution (ca. 1000 pfu) was
inoculated per egg. In the case of DI stocks, 0.1 ml of a 102 to
104 dilution was used. In all cases, the amount of viral proteins
present in the resulting allantoic fluid was analyzed by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and
Coomassie blue staining of pelleted virus. Virus titers were
determined by plaquing on LLC-MK2 cells. Anti-IRF-3 (Santa
Cruz), anti-actin (Chemicon), anti-Stat1 (C-terminus) (Trans-duction Laboratories), anti-N-877 and anti-PCV, anti-ISG-15
and anti-ISG-56 were provided by Dr. Ganes Sen from The
Cleveland Clinic Institute. Anti-Rig-I was provided by Tadaatsu
Imaizumi from Hirosaki University School of Medicine.
Plasmids, transient transfections, luciferase assay and FACS
pβ-IFN-fl-lucter, which contains the firefly luciferase gene
under the control of the human IFNβ promoter, is described in
King and Goodbourn (1994). The IFNα/β-responsive reporter
plasmid, p(9–27)4tkD(239)lucter, referred to here as pISRE-fl-
lucter, contains four tandem repeats of the IFN-inducible gene
9–27 ISRE fused to the firefly luciferase gene (Didcock et al.,
1999). pTK-rl-lucter used as a transfection standard contains the
herpes simplex virus TK promoter region upstream of the renilla
luciferase gene (Promega). pIRF-3ΔN, which expresses a
dominant negative form of IRF-3, and pIRF-3 5D, which is
constitutively active, were obtained from John Hiscott and
Paula Pitha (Lin et al., 1998).
For transfections, 100,000 cells were plated in six-well plates
20 h before transfection with 1 μg of pβ-IFN-fl-lucter or pISRE-
fl-lucter, 0.3 μg of pTK-rl-lucter, with or without 1 μg of IRF-
3ΔN, or 1 μg of EBS plasmid expressing SeV-V protein (Nishio
et al., 2005), and Fugene (Roche) according to the manufac-
turer's instructions. At 24 h post-transfection, the cells were (or
were not) infected with various Sendai virus stocks or treated
with 100 μg of poly(I)–poly(C) (Sigma, St. Louis, MO) per ml or
transfected with 1 μg of poly(I)–poly(C) using Fugene. Twenty
hours later, cells were harvested and assayed for firefly and
renilla luciferase activity (dual-luciferase reporter assay system;
Promega). Relative expression levels were calculated by
dividing the firefly luciferase values by those of renilla
luciferase. pIFNβ-GFP, which expresses GFP under the control
of the IFNβ promoter, was constructed by cloning the IFNβ
promoter region from pIFNβ-fl-lucter into pEGFP-N3 (BD
Biosciences Clontech), between the AseI and HindIII sites. For
transfections, 100,000 cells were plated in six-well plates 20 h
before transfection with 1 μg of pIFNβ-GFP and CaPO4
(Stratagene) according to the manufacturer's instructions. At
24 h post-transfection, the cells were (or were not) infected with
Sendai virus or different DI stocks. Twenty hours later, cells were
harvested and assayed for GFP expression by FACS analysis.
Preparation of DI-H4+yfp
100,000 BSR-T7 cells were plated in six-well plates 20 h
before transfection with a mix containing 0.75 μg of pTM1-L,
1.5 μg of pTM1-N, 1.5 μg of pTM1-P/Cstop (which does not
express C proteins), 1 μg of the various pDI constructs and
Fugene. Six hours later, the transfection mix was discarded and
replaced with 2 ml of Glasgow MEM supplemented with 5%
FCS. Twenty four hours post-transfection, the cells were
infected with ND SeV. Forty eight hours post-infection, the
cells were scraped into their medium and injected directly into
the allantoic cavity of 9-day embryonated chicken eggs. Three
days later, the allantoic fluids were harvested and injected
undiluted into eggs. For further passages, the virus stocks were
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500 before injection. The presence of viruses in the resulting
stock was determined by pelleting allantoic fluids (100 μl)
through a TNE (10 mM Tris–HCl [pH 8.0], 100 mM NaCl,
1 mM EDTA)–25% glycerol cushion for 20 min at 14,000 rpm
in an Eppendorf 5417C centrifuge. Virus pellets were
resuspended in sample buffer, and the proteins were separated
by sodium dodecyl sulfate–10% PAGE and stained with
Coomassie brilliant blue, alongside an ND stock of known titer.
Analysis of encapsidated RNAs
Confluent 293T cells in 9 cm ∅ Petri dishes (2 × 107 cells)
were infected with 10 pfu/cell of ND stocks, and an equivalent
amount of viral protein for DI stocks. Two days post-infection,
the cells were collected, and the intracellular viral nucleocapsids
(NC) were purified by 20–40% (w/w) CsCl density gradient
centrifugation and pelleted. After treatment with SDS and
proteinase K, the nucleocapsid RNAs were phenol-extracted
and ethanol-precipitated. The resulting RNAs were character-
ized by Taqman analysis using specifics oligonucleotides and
Taqman probes and by Northern blotting using a biotinylated
riboprobe generated in vitro by T7 RNA polymerase transcrip-
tion of plus strands complementary to nucleotides 13,397–
14,850 of the (−) ND genome.
Reverse transcription and real-time PCR via Taqman
Total RNA was extracted using Trizol (Invitrogen). Twenty
micrograms of total RNA was mixed with 0.5 μg Random
Hexamers (Promega) and subjected to a Superscript reverse
transcription (RT) reaction as described by the manufacturer
(Gibco) in a total volume of 50 μl. Two microliters of each
cDNA was then combined with 1 μl of internal control
Human GAPDH (Applied Biosystems), 11 μl MasterMix
(Eurogentec), 20 pmol (each) of forward and reverse primers
and 4.4 pmol of Taqman probe in a total volume of 22 μl.
The following primers and probes (Eurogentec or Microsynth)
were used: N gene: 5′-GCAATAACGGTGTCGATCACG-3′
(Fwd); 5′-TGCCTGAGCCGATCGG-3′ (Rev); 5′-CGAAGAT-
GACGATACCGCAGCAGTAGC-3′ (Probe). YFP gene:
5′-CCGACAACCACTACCTGAGCTA-3′ (Fwd); 5′-GAACTC-
CAGCAGGACCATGTG-3′ (Rev); 5′-AAAGACCCCAACGA-
GAAGCGCGA-3′ (Probe). Real-time PCR was carried out in the
7700 Sequence Detector (Applied Biosystems).
Acknowledgment
This work was supported by the Swiss National Science
Fund.
References
Andrejeva, J., Childs, K.S., Young, D.F., Carlos, T.S., Stock, N.,
Goodbourn, S., Randall, R.E., 2004. The V proteins of paramyxoviruses
bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation
of the IFN-beta promoter. Proc. Natl. Acad. Sci. U.S.A. 101,
17264–17269.Calain, P., Curran, J., Kolakofsky, D., Roux, L., 1992. Molecular cloning of
natural paramyxovirus copy-back defective interfering RNAs and their
expression from DNA. Virology 191, 62–71.
Chanda, P.K., Kang, C.Y., Banerjee, A.K., 1980. Synthesis in vitro of the full-
length complement of defective-interfering particle RNA of vesicular
stomatitis virus. Proc. Natl. Acad. Sci. U.S.A. 77, 3927–3931.
Curran, J., Boeck, R., Kolakofsky, D., 1991. The Sendai virus P gene expresses
both an essential protein and an inhibitor of RNA synthesis by shuffling
modules via mRNA editing. EMBO J. 10, 3079–3085.
Delenda, C., Taylor, G., Hausmann, S., Garcin, D., Kolakofsky, D., 1998. Sendai
viruses with altered P, V, and W protein expression. Virology 242, 327–337.
Didcock, L., Young, D.F., Goodbourn, S., Randall, R.E., 1999. Sendai virus and
simian virus 5 block activation of interferon-responsive genes: importance
for virus pathogenesis. J. Virol. JID-0113724 73, 3125–3133.
Engelhorn, M., Stricker, R., Roux, L., 1993. Molecular cloning and
characterization of a Sendai virus internal deletion defective RNA. J. Gen.
Virol. 74, 137–141.
Fitzgerald, K.A., McWhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E.,
Golenbock, D.T., Coyle, A.J., Liao, S.M., Maniatis, T., 2003. IKKepsilon
and TBK1 are essential components of the IRF3 signaling pathway. Nat.
Immunol. 4, 491–496.
Frey, T.K., Jones, E.V., Cardamone Jr., J.J., Youngner, J.S., 1979. Induction of
interferon in L cells by defective-interfering (DI) particles of vesicular
stomatitis virus: lack of correlation with content of [+/−] snapback RNA.
Virology 99, 95–102.
Fujii, Y., Sakaguchi, T., Kiyotani, K., Huang, C., Fukuhara, N., Egi, Y., Yoshida,
T., 2002. Involvement of the leader sequence in Sendai virus pathogenesis
revealed by recovery of a pathogenic field isolate from cDNA. J. Virol. 76,
8540–8547.
Garcin, D., de Melo, M., Roux, L., Kolakofsky, D., Curran, J., 1994. Presence of
a truncated form of the Sendai virus P protein in a long-term persistent
infection: implications for the maintenance of the persistent state. Virology
200.
Garcin, D., Pelet, T., Calain, P., Roux, L., Curran, J., Kolakofsky, D., 1995. A
highly recombinogenic system for the recovery of infectious Sendai
paramyxovirus from cDNA: generation of a novel copy-back nondefective
interfering virus. EMBO J. 14, 6087–6094.
Garcin, D., Taylor, G., Tanebayashi, K., Compans, R., Kolakofsky, D., 1998.
The short Sendai virus leader region controls induction of programmed cell
death. Virology 243, 340–353.
Garcin, D., Latorre, P., Kolakofsky, D., 1999. Sendai virus C proteins counteract
the interferon-mediated induction of an antiviral state. J. Virol. 73,
6559–6565.
Gotoh, B., Takeuchi, K., Komatsu, T., Yokoo, J., Kimura, Y., Kurotani, A., Kato,
A., Nagai, Y., 1999. Knockout of the Sendai virus C gene eliminates the viral
ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett.
459, 205–210.
Hasegawa, H., Yoshida, M., Shiosaka, T., Fujita, S., Kobayashi, Y., 1992.
Mutations in the envelope protein of Japanese encephalitis virus affect entry
into cultured cells and virulence in mice. Virology 191, 158–165.
He, B., Paterson, R.G., Stock, N., Durbin, J.E., Durbin, R.K., Goodbourn, S.,
Randall, R.E., Lamb, R.A., 2002. Recovery of Paramyxovirus simian virus 5
with a V protein lacking the conserved cysteine-rich domain: the
multifunctional V protein blocks both interferon-beta induction and
interferon signaling. Virology 303, 15–32.
Hiscott, J., Grandvaux, N., Sharma, S., Tenoever, B.R., Servant, M.J., Lin, R.,
2003. Convergence of the NF-kappaB and interferon signaling pathways in
the regulation of antiviral defense and apoptosis. Ann. N. Y. Acad. Sci. 1010,
237–248.
Iseni, F., Garcin, D., Nishio, M., Kedersha, N., Anderson, P., Kolakofsky, D.,
2002. Sendai virus trailer RNA binds TIAR, a cellular protein involved in
virus-induced apoptosis. EMBO J. 21, 5141–5150.
Johnston, M.D., 1981. The characteristics required for a Sendai virus
preparation to induce high levels of interferon in human lymphoblastoid
cells. J. Gen. Virol. 56, 175–184.
Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T., Nagai, Y., 1997. The
paramyxovirus, Sendai virus, V protein encodes a luxury function required
for viral pathogenesis. EMBO J 16, 578–587.
111L. Strahle et al. / Virology 351 (2006) 101–111Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J.,
Takeuchi, O., Akira, S., 2005. IPS-1, an adaptor triggering RIG-I- and
Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981–988.
King, P., Goodbourn, S., 1994. The beta-interferon promoter responds to
priming through multiple independent regulatory elements. J. Biol. Chem.
269, 30609–30615.
Kolakofsky, D., 1976. Isolation and characterization of Sendai virus DI-RNAs.
Cell 8, 547–555.
Lamb, R.A., Kolakofsky, D., 2001. Paramyxoviridae: the viruses and their
replication. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, vol. 1.
Lippincott, Williams and Wilkins, pp. 1305–1340.
Lazzarini, R.A., Keene, J.D., Schubert, M., 1981. The origins of defective
interfering particles of the negative-strand RNA viruses. Cell 26, 145–154.
Le Mercier, P., Garcin, D., Hausmann, S., Kolakofsky, D., 2002. Ambisense
sendai viruses are inherently unstable but are useful to study viral RNA
synthesis. J. Virol. 76, 5492–5502.
Lin, R., Heylbroeck, C., Pitha, P.M., Hiscott, J., 1998. Virus-dependent
phosphorylation of the IRF-3 transcription factor regulates nuclear
translocation, transactivation potential, and proteasome-mediated degrada-
tion. Mol. Cell. Biol. 18, 2986–2996.
Lin, R., Mamane, Y., Hiscott, J., 1999. Structural and functional analysis of
interferon regulatory factor 3: localization of the transactivation and
autoinhibitory domains. Mol. Cell. Biol. 19, 2465–2474.
Maniatis, T., Falvo, J.V., Kim, T.H., Kim, T.K., Lin, C.H., Parekh, B.S.,
Wathelet, M.G., 1998. Structure and function of the interferon-beta
enhanceosome. Cold Spring Harbor Symp. Quant. Biol. 63, 609–620.
Marcus, P.I., Gaccione, C., 1989. Interferon induction by viruses. XIX. Vesicular
stomatitis virus-New Jersey: high multiplicity passages generate interferon-
inducing defective-interfering particles. Virology 171, 630–633.
Marcus, P.I., Sekellick, M.J., 1977. Defective interfering particles with
covalently linked [+/−]RNA induce interferon. Nature 266, 815–819.
McWhirter, S.M., Tenoever, B.R., Maniatis, T., 2005. Connecting mitochondria
and innate immunity. Cell 122, 645–647.
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartens-
chlager, R., Tschopp, J., 2005. Cardif is an adaptor protein in the RIG-I
antiviral pathway and is targeted by hepatitis C virus. Nature 437,
1167–1172.
Nishio, M., Tsurudome, M., Ito, M., Garcin, D., Kolakofsky, D., Ito, Y., 2005.
Identification of paramyxovirus V protein residues essential for STAT
protein degradation and promotion of virus replication. J. Virol. 79,
8591–8601.Perrault, J., 1981. Origin and replication of defective interfering particles. Curr.
Top. Microbiol. Immunol. 93, 151–207.
Poole, E., He, B., Lamb, R.A., Randall, R.E., Goodbourn, S., 2002. The V
proteins of Simian virus 5 and other paramyxoviruses inhibit induction of
interferon-beta. Virology 303, 33–46.
Roux, L., Simon, A.E., Holland, J.J., 1991. Effects of defective interfering
viruses on virus replication and pathogenesis. Advances in Virus Research,
vol. 40. Academic Press Inc., pp. 181–211.
Sekellick, M.J., Marcus, P.I., 1982. Interferon induction by viruses. VIII.
Vesicular stomatitis virus: [+/−]DI-011 particles induce interferon in the
absence of standard virions. Virology 117, 280–285.
Sen, G.C., 2001. Viruses and interferons. Annu. Rev. Microbiol. 55, 255–281.
Seth, R.B., Sun, L., Ea, C.K., Chen, Z.J., 2005. Identification and
characterization of MAVS, a mitochondrial antiviral signaling protein that
activates NF-kappaB and IRF 3. Cell 122, 669–682.
Sharma, S., Tenoever, B.R., Grandvaux, N., Zhou, G.P., Lin, R., Hiscott, J.,
2003. Triggering the interferon antiviral response through an IKK-related
pathway. Science 300, 1148–1151.
Simmonds, P., Tuplin, A., Evans, D.J., 2004. Detection of genome-scale
ordered RNA structure (GORS) in genomes of positive-stranded RNA
viruses: implications for virus evolution and host persistence. RNA 10,
1337–1351.
Strahle, L., Garcin, D., Le Mercier, P., Schlaak, J.F., Kolakofsky, D., 2003.
Sendai virus targets inflammatory responses, as well as the interferon-
induced antiviral state, in a multifaceted manner. J. Virol. 77,
7903–7913.
Sumpter Jr., R., Loo, Y.M., Foy, E., Li, K., Yoneyama, M., Fujita, T.,
Lemon, S.M., Gale Jr., M., 2005. Regulating intracellular antiviral
defense and permissiveness to hepatitis C virus RNA replication through
a cellular RNA helicase, RIG-I.J. Virology 79, 2689–2699.
Vidal, S., Kolakofsky, D., 1989. Modified model for the switch from Sendai
virus transcription to replication. J. Virol. 63, 1951–1958.
Xu, L.G., Wang, Y.Y., Han, K.J., Li, L.Y., Zhai, Z., Shu, H.B., 2005. VISA is an
adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19,
727–740.
Yoneyama, M., Suhara, W., Fujita, T., 2002. Control of IRF-3 activation by
phosphorylation. J. Interferon Cytokine Res. 22, 73–76.
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T.,
Miyagishi, M., Taira, K., Akira, S., Fujita, T., 2004. The RNA helicase RIG-
I has an essential function in double-stranded RNA-induced innate antiviral
responses. Nat. Immunol. 5, 730–737.
